Glucagon-like peptide-2 and its therapeutic use
US5990077A · kind A · utility
79Cited by
0References
80Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 14, 1995 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Apr 14, 2015 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glucagon-like peptide 2, a product of glucagon gene expression, has been identified as a gastrointestinal tissue growth factor. Its effects on the growth of small intestine and on pancreatic islets are described. Its formulation as a pharmaceutical, and its therapeutic use in treating bowel tissue disorders and in treating diabetes, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.